• No results found

Innovative Process of Texturing-Assisted Solvent Extraction: Impacts on Polyphenols, Flavonoids, Tannins and Antioxidant of Henna.

N/A
N/A
Protected

Academic year: 2020

Share "Innovative Process of Texturing-Assisted Solvent Extraction: Impacts on Polyphenols, Flavonoids, Tannins and Antioxidant of Henna."

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 2. Temperature–time relationship in a DIC cycle.
Figure 4. Effect of C (methanol:water concentration) on solvent TPC extraction from Henna Leaves
Table 4.  DIC operating parameters (independent variables) and Total Phenolic Content (TPC), Total Flavonoids Content (TFC), Condensed Tannin, and Anti-
Figure 6. Pareto chart of DIC operating parameters (A), general trends (B), and response surface (C) for TPC extracted from Henna
+6

References

Related documents

Con- sidering that virulence process involves several essential factors including toxins, various pathogen-derived secre- tion proteins were also included in the database, and it

Keywords: Speech synthesis; Harmonic model; Phase modeling; Voice transformation; Parametric speech synthesis..

Previous gene expression studies with inbred chicken lines that have distinct responses to NDV [4,8-12] have contributed to understanding gene regulation of Newcastle disease

Terminalia b. and Acanthaceae spp. extracts were obtained by solvent extraction method using water. The kitchen waste substrate was analyzed for physical-chemical parameters and

hok / sok locus delays the onset of growth of bacteria cell cultures, and enables the cells to. grow rapidly at a later stage, despite the prevailing/unfavourable

Ministry of health should prioritize funding for the Integrated Management of Childhood Illnesses and revising the Essential Medicines and Health Supplies List of Uganda, the

bassiana isolates from the mycovirus infection and comparing the isogenic lines in terms of e.g., growth and germination, UV-tolerance, spore production, and pathogenicity against

Comparison of the frequency of CHEK2 variants in 7540 patients (4454 with breast cancer, 1085 with colorectal cancer, 2001 with other tumours excluding prostate cancer) to that